Yediyurappa appeals for support to 'Janata Curfew'

Bengaluru, May 3: The Excise Commissioner of Karnataka has issued an order granting permission to distilleries, breweries and wineries situated outside the containment zones to begin production activity. The permission has been granted on the condition that they strictly comply with COVID-19 related guidelines issued by the Ministry of Home Affairs.

"In view of the state government order and the new guidelines issued by the MHA, permission is granted to distilleries, breweries and wineries situated in rural areas and industrial estates and industrial townships with access control (outside containment zones) to commence only production activity," the Excise Commissioner said in the order.

The Excise Commissioner further said in the order that the Deputy Commissioner of Excise shall ensure that wherever distilleries, breweries and wineries are permitted to carry on production activities, they shall strictly comply with COVID-19 related guidelines issued by the MHA.

Bengaluru, Apr 15: The Karnataka government on Wednesday opened a critical care support unit to monitor the progress of Coronavirus patients in Intensive Care Units (ICUs) of various designated COVID hospitals across the State.

Karnataka is the first state in the country to establish a dedicated unit for critical care support, by linking ICUs of COVID hospitals onto a single platform, Medical Education Minister Sudhakar K, who inaugurated it, was quoted as saying in a statement on Wednesday.

Its objective is to monitor COVID-19 patients in ICUs across Karnataka state so that the hospitals are prepared for the potential onslaught of the virus and thereby to achieve zero COVID mortality in Karnataka, he said, adding, it would enable capturing details of ICU COVID-19 patients in real-time

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.